Occudo Quantitative Strategies’s Outset Medical OM Stock Holding History

Occudo Quantitative Strategies’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-5,107	Closed	-$170K	–	927
2024 Q1	$170K	Buy	5,107 +110	+2%	+$5.57K	0.03%	613
2023 Q4	$405K	Buy	+4,997	New	+$407K	0.06%	455
2023 Q3	–	Sell	-726	Closed	-$238K	–	1214
2023 Q2	$238K	Buy	+726	New	+$221K	0.02%	801
2021 Q3	–	Sell	-435	Closed	-$326K	–	1107
2021 Q2	$326K	Buy	+435	New	+$332K	0.05%	569

Other funds holding OM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

MIC

Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return

Occudo Quantitative Strategies's OM Position: Q2 2024 in Review

Occudo Quantitative Strategies sold out of Outset Medical (OM) in Q2 2024, closing a stake of 5,107 shares — an estimated $170K sold.

Occudo Quantitative Strategies first reported a position in OM in Q2 2021 and held it in 4 quarters. The position peaked at $405K in Q4 2023. 122 funds tracked by Wall St. Rank hold OM as of Q2 2024.

Occudo Quantitative Strategies reported no remaining Outset Medical position as of Q2 2024 after selling out during the quarter.
Occudo Quantitative Strategies sold 5,107 Outset Medical shares in Q2 2024, an estimated $170K.
Occudo Quantitative Strategies first reported a position in Outset Medical in Q2 2021 and held it in 4 quarters.
Occudo Quantitative Strategies's Outset Medical position peaked at $405K in Q4 2023.
122 funds tracked by Wall St. Rank held Outset Medical as of Q2 2024.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2024, filed 14 Aug 2024.